Haemonetics accounting chief reports disposal of $309,924.04 in common shares
HAE•Haemonetics VP and Chief Accounting Officer Maryanne Maunsell Farris reported disposing of common shares worth $309,924.04 and exercising options; her directly owned holdings totaled 5,828 shares afterward.
1. Share transactions
Farris sold 836 common shares at $120.99 on Nov. 11, 2026, and disposed of an additional 1,724 shares at $121.10. She exercised non-qualified stock options for 1,068 shares at $89.16, 645 shares at $95.73 and 433 shares at $70.31. Her directly owned holdings totaled 5,828 common shares following the transactions.
